Aedicell Expands Availability of Advanced Wound Therapies to US Patients

According to recent news, Aedicell has secured a Group Purchasing Agreement with Premier, Inc., which will allow them to provide for a growing number of patients who require advanced regenerative wound therapies. Aedicell also shared plans for a new production facility in Cape May County, NJ, in addition to its American Association of Tissue Banks certified facility in Rochester, NY. This expansion will help accommodate the projected demands within the community.

Ted Burke, CEO of Aedicell, commented that the company works to change the lives of people needing skin substitutes by transforming human tissue into therapies. The company’s expansion and growth will allow more people to access these therapies at a lower cost. In support of that growth, the company’s new facility in New Jersey will enable them to meet the demand of the products.

To learn more about the company’s plans, visit Aedicell’s website.

Source: Aedicell